Matches in Nanopublications for { ?s ?p "[We hypothesized that a CRAd armed with osteoprotegerin (OPG), an inhibitor of osteoclastogenesis, would inhibit the progression of prostate cancer bone metastases by directly lysing tumor cells and by reducing osteoclast activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP370161.RAYz3uGqRlT43ylSLCL6en3dB9r59sAHBt2gNKoRNEbNQ130_assertion description "[We hypothesized that a CRAd armed with osteoprotegerin (OPG), an inhibitor of osteoclastogenesis, would inhibit the progression of prostate cancer bone metastases by directly lysing tumor cells and by reducing osteoclast activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370161.RAYz3uGqRlT43ylSLCL6en3dB9r59sAHBt2gNKoRNEbNQ130_provenance.
- NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_assertion description "[We hypothesized that a CRAd armed with osteoprotegerin (OPG), an inhibitor of osteoclastogenesis, would inhibit the progression of prostate cancer bone metastases by directly lysing tumor cells and by reducing osteoclast activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408186.RAEFT4gSR8aMZlJresABtwM92slztBw48baHitbBzgyDA130_provenance.